Controls for Blood Septicemia Nucleic Acid Tests Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT XIX Meeting Berne, Switzerland.

Slides:



Advertisements
Similar presentations
Analytical Sensitivity of the Urine-Based APTIMA® Trichomonas vaginalis molecular assay using the automated Tigris® Platform A.H. Freeman1, M.W. Pandori2,
Advertisements

By Gracie Canales August 10, 2010
SEPTICAEMIA Dr. Urvesh V. Shah Associate Professor Editor in Chief, Dept. of Microbiology, GCSMC Journal Of GCS Medical College Medical Sciences.
Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Ebola Virus Disease (EVD) Laboratory Diagnostics 04/12/2014.
Yi-Chen Yang, Drug Biology Division Bureau of Food and Drug Analysis Department of Health, Taiwan Collaborative study for establishment of the first national.
Blood Culture. Bacteremia: Types  Transient: Disruption of mucosal surfaces (dental or surgical procedures)  Intermittent: Associated with abscesses.
Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:
Linearity Panels HIV RNA, HCV RNA, HBV DNA, and CMV DNA
Nucleic Acid Extraction Control in Real-Time PCR Assays Steve Hawkins Senior Global Product Manager Bioline.
Diagnostic Microbiology and Immunology
Assays Molecular Diagnostics CSULA. What’s a molecular diagnostic assay? n A laboratory test for the presence or absence of a particular type of molecule.
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
OnSite Gonorrhea Rapid Test (Strip)
COBAS TaqMan 48 Sales Brochure
R Diagnostics June 19, 2003 WNV FDA BPAC MeetingPCR NAT Blood Screening TaqScreen West Nile Virus Program - Roche Update James L. Gallarda, Ph.D. Roche.
Laboratory Investigation
HIV Testing Quality Assurance and Quality Control
Microbiological Considerations in Diagnosing S. aureus Bacteremia Patrick R. Murray, Ph.D. NIH Clinical Center Chief, Microbiology Laboratories.
General Approach of Haemostasis
Quality Assessment 2 Quality Control.
HIV, HCV, and HBV NAT Controls Formulation, Stability and Performance Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT.
Quantification of RNA by real-time PCR
Introduction to Analytical Chemistry Dr M. Abd-Elhakeem Faculty of Biotechnology General Chemistry Lecture 7.
Overview of the presentation 1.The LiMA technology 2.Sensitivity for ligase detection 3.Sensitivity for bacterial detection.
Bacterial Screening of Platelet Concentrates by Real-Time PCR Theo Cuypers 1 also on behalf of, H.W. Reesink 1,3 I.G.H. Rood 1,2 T. Mohammadi¹, ²P.H.M.
Validating the Micro PRO™ Technology. Overview of Today’s Presentation Validation Resources Micro PRO™ Applications and Corresponding Validation Parameters.
Approval Criteria for Assays for Testing Blood Donors for West Nile Virus Robin Biswas, M.D. CBER, FDA Blood Products Advisory Committee Meeting March.
Qualification Panels for West Nile Virus RNA Tests Mark Manak, Ph.D. Boston Biomedica, Inc. West Bridgewater, MA SoGAT Langen, Germany July 3, 2003.
Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples stored at different temperatures Marta José, Rodrigo Gajardo and Juan I. Jorquera Instituto.
Quality Control Lecture 5
Julia Robbins August 11, Objectives Clinical Significance of MRSA in Healthcare Setting Principle of assay Assay Procedure Assay Perfomance.
A RAPID AND INNOVATIVE METHOD FOR THE IDENTIFICATION OF THE COMMONEST G6PD ITALIAN MUTATIONS A. Minucci, L. Gentile, S. Rocchetti, C. Zuppi, B. Giardina.
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
• TEMPO® Concept • Workflow
Molecular Techniques in Microbiology These include 9 techniques (1) Standard polymerase chain reaction Kary Mullis invented the PCR in 1983 (USA)Kary.
Xenotropic Murine Leukemia Virus-Related Retrovirus: CCR Assay Development.
X. James Li, Ph.D. Cellex, Inc.. Topics  Homogeneous Biochemiluminescence Assays (HBA) and Its Use for Detection of Influenza Viral Neuraminidase (NA)
Active B19 virions production in hepatoblastoma and hepatocarcinoma cell lines: amplification and genomic stability. Op de beeck A. 1, Draps M.-L. 1, Baurin.
Update on the P. falciparum Standard & Replacement of the HBV & HCV International Standards Sally Baylis, NIBSC SoGAT XIX.
1 BacTx ™ Kit for Detection of Bacterial Contamination of Platelets Andrew E. Levin, Ph.D. Immunetics, Inc. Blood Products Advisory Council Meeting March.
Catheter-related blood stream infections. Objectives 1.Catheter-related blood stream infections - Present scenario 2.Methods of diagnosing CRBSI 3.Importance.
Preparation of HBV DNA reference standards and the experience of HBV NAT in Taiwan Dr. Hwei-Fang Cheng Department of Health, Taiwan.
Solutions used in medical laboratory. O Solution is a homogeneous mixture of two or more substances. O Solute is the dissolved substance, whereas solvent.
QC/QA.
Dr Ngo Tat Trung, PhD Danang– September 2015
Factor V Leiden Detection and Genotyping
Gülden Çelik. Learning Objectives At the end of this lecture, the student should be able to: Define bacteremia, fungemia, and sepsis List the main types.
DRK-Blutspendedienst West  nPrecipitation steps (PEG), centrifugation and careful resuspension of the invisible pelleted viral particles precede efficient.
Confidential Extending the Armored RNA Technology to DNA Cindy WalkerPeach, Ph.D. Director, Development and Operations Ambion Diagnostics BSI EN ISO9001:2000.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
The Factor II (Prothrombin) G20210A Detection and Genotyping
CONCLUSIONS Amended Abstract Detection of GBS Directly from ESwab Collected Samples Using the BD MAX™ GBS Assay Suzane Silbert, Talita T. Rocchetti, Alicia.
Procalcitonin 정량검사의 평가
Diagnostic clinical chemistry
Prof. Hee-Joo, Lee May, 11, Introduction Dx of pneumococcal infection : –Culture methods –Nucleic acid amplification –Ag detection BinaxNow S.pneumoniae.
Point of Care Diagnostics for Hospital Acquired Infections (HAIs): Health Economics Perspective Detection & Identification of Infectious Agents (DIIA)
Move over culture Rapid and accurate quantification of Mycobacterium tuberculosis in sputum samples takes just one day Centre for Clinical Microbiology.
Result Introduction Methods
General Approach of Haemostasis
General Approach in Investigation of Hemostasis
2011 American Society for Microbiology Meeting
Detection of bacteria in blood products
Real-Time Polymerase Chain Reaction for Detecting Bacterial DNA Directly from Blood of Neonates Being Evaluated for Sepsis  Jeanne A. Jordan, Mary Beth.
Applied Biosystems™ Consumables on Bio-Rad CFX™
Real-Time Polymerase Chain Reaction for Detecting Bacterial DNA Directly from Blood of Neonates Being Evaluated for Sepsis  Jeanne A. Jordan, Mary Beth.
Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.
Presentation transcript:

Controls for Blood Septicemia Nucleic Acid Tests Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT XIX Meeting Berne, Switzerland June 15, 2006

Sepsis: Infection of Blood Stream Bacterial infection (Bacteremia); Fungal Infection (Candidemia) Second leading cause of death among patients in non-coronary intensive care units (ICU) Tenth leading cause of death overall in US Usually diagnosed by culture using specialized apparatus to detect and identify any viable microorganisms. Limitations of Blood Culture –Relatively insensitive and time consuming: 24 to 48 hrs to results –>30% of septic patients are false negative by blood culture

Nucleic Acid Tests for Sepsis Roche SeptiFast TM Test Highly specific – able to detect <100 organisms per ml blood Detects microorganisms that cause >90% of all blood stream infections Real Time PCR on Light Cycler Platform 3 parallel reactions: gram positive, gram negative, and fungus Melting curve analysis of end product ensures proper sequence Rapid, automated results in less than 5 hours

ACCURUN 500 Design Specifications Manufactured from P. aeruginosa, S. aureus, and C. albicans Inactivated to reduce viability >6 logs. Diluted in negative human plasma Targeted at low concentration (about 300 CFU/ml ) Intended Use Estimate laboratory testing precision Detect errors in laboratory testing procedures. Controls for the entire workflow

Linearity of C. albicans in SeptiFast Test

100 cfu/reaction Quantification -Channel 640 C. albicans Tm Calling – Channel 640 NHP 100 cfu/reaction NHP IC

Quantification -Channel 670 P. aeruginosa Tm Calling – Channel cfu/reaction NHP

Excellent Reproducibility: Multiple Lots, Test Sites Test Site A Test Site B Mean: SD: %CV: 5% 4% 2% Test Site A Test Site B Lot Number S. aureus P. aeriginosa C. albicans cp

Stability Studies Accelerated Stability 37 o C Freeze-Thaw Stability

ACCURUN 500 Summary Stable, low reactive independent quality control material Made from natural bacteria in plasma diluent to mimic clinical sample Controls for all test steps: extraction, amplification and detection Well suited for the quality control of Nucleic Acid assays for microorganisms in human blood. Gram positive, Gram negative and fungal controls showed amplification peaks only in the respective channels for all lots Negative controls showed Internal Control peaks only Excellent Reproducibility between Control Lots, Test Runs, and Test Sites Use of ACCURUN 500 will allow laboratories to detect immediate testing errors and monitor the long term performance of such assays.